Rankings
▼
Calendar
PRGO Q3 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q3 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.1B
+2.1% YoY
Gross Profit
$411M
36.6% margin
Operating Income
$62M
5.5% margin
Net Income
$14M
1.3% margin
EPS (Diluted)
$0.11
QoQ Revenue Growth
-5.8%
Cash Flow
Operating Cash Flow
$125M
Free Cash Flow
$93M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$10.8B
Total Liabilities
$6.0B
Stockholders' Equity
$4.7B
Cash & Equivalents
$598M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$1.1B
+2.1%
Gross Profit
$411M
$363M
+13.3%
Operating Income
$62M
$33M
+87.6%
Net Income
$14M
-$49M
+128.7%
Revenue Segments
Consumer Self-Care Americas
$704M
63%
Consumer Self-Care International
$420M
37%
Geographic Segments
UNITED STATES
$690M
61%
Europe
$400M
35%
Other Geographical Areas
$34M
3%
IRELAND
$12M
1%
← FY 2023
All Quarters
Q4 2023 →